Labelled Nucleotides

Patent No. EP1451351 (titled "Labelled Nucleotides") was filed by Illumina Cambridge on Dec 4, 2002. The application was issued on Feb 1, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEOct 30, 2017HOFFMANN EITLE
KILGER, CHRISTIANFeb 1, 2017CH KILGER ANWALTSPARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP1451351

ILLUMINA CAMBRIDGE
Application Number
EP02781434A
Filing Date
Dec 4, 2002
Status
Revoked
Feb 9, 2024
Publication Date
Feb 1, 2017